Diagnostic biomarkers of ischemic stroke: strengths and limitations across blood, urine, and saliva - Takeaways - MDSpire

Diagnostic biomarkers of ischemic stroke: strengths and limitations across blood, urine, and saliva

  • By

  • Begüm Utz

  • Pihla Miettinen

  • Ivette Bañuelos-Cabrera

  • Leonardo Lara-Valderrábano

  • Lasse Välimaa

  • Adrian Harel

  • June 17, 2026

  • 0 min

Share

  • 1

    Ischemic stroke is a leading cause of death and disability, requiring rapid diagnosis to save brain tissue.

  • 2

    Neuroimaging is the preferred diagnostic method but is often unavailable in low-resource settings.

  • 3

    Blood-based biomarkers, particularly brain-specific proteins, show promise for early ischemic stroke diagnosis.

  • 4

    Urine and saliva biomarkers are being researched but lack validation in larger patient groups.

  • 5

    No single biomarker is sufficient for early ischemic stroke diagnosis; multi-marker strategies are needed.

Original Source(s)

Related Content